tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Esther Rajavelu, 63 are a BUY (81.82%), 5 are a SELL (6.49%), 9 are a HOLD (11.69%).
Analyst Esther Rajavelu, carries an average stock price target met ratio of 64.02% that have a potential upside of 28.41% achieved within 319 days. Previously, Esther Rajavelu worked at UBS, DEUTSCHE BANK, JPMORGAN, OPPENHEIMER.
Esther Rajavelu’s has documented 157 price targets and ratings displayed on 23 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 12-Aug-2025.
Analyst best performing recommendations are on VNDA (VANDA PHARMACEUTICALS).
The best stock recommendation documented was for VNDA (VANDA PHARMACEUTICALS) at 2/14/2019. The price target of $21 was fulfilled within 1 day with a profit of $0.88 (4.37%) receiving and performance score of 43.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-May-2025
$375
$169.48 (82.46%)
$400
1 days ago
(31-Jul-2026)
10/12 (83.33%)
$169.48 (82.46%)
28
Hold Since 24-Feb-2023
$300
$94.48 (45.97%)
$400
1 days ago
(31-Jul-2026)
11/14 (78.57%)
$94.48 (45.97%)
37
Buy Since 07-Aug-2018
$318
$112.48 (54.73%)
$508
1 days ago
(31-Jul-2026)
26/29 (89.66%)
$112.48 (54.73%)
201
Buy Since 10-Oct-2023
$350
$144.48 (70.30%)
$470
1 days ago
(31-Jul-2026)
14/15 (93.33%)
$144.48 (70.30%)
90
Buy Since 19-Dec-2019
$425
$219.48 (106.79%)
$425
1 days ago
(31-Jul-2026)
12/15 (80%)
$219.48 (106.79%)
252
What Year was the first public recommendation made by Esther Rajavelu?
